Premium
Second trimester maternal serum β human chorionic gonadotrophin and pregnancy outome
Author(s) -
Mikic Taita Stojilkovic,
Johnson Pam
Publication year - 1999
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1999.tb08331.x
Subject(s) - medicine , pregnancy , obstetrics , second trimester , prospective cohort study , gynecology , intrauterine growth restriction , gestation , biology , genetics
The aim of this prospective, controlled study was to examine the relation between second trimester maternal serum β human chorionic gonadotrophin (HCG) and birthweight. The study population con sisted of 192 women with maternal serum βHCG ≥ 3.5 multiple of the median and a control group with the same number of women with maternal serum βHCG ≥ 2.0 multiple of the median. There was no difference in birthweight and other pregnancy outcomes between the two groups. When used prospectively, elevated βHCG in the mid‐trimester is not a predictor for intrauterine growth restriction or other pregnancy complications.